Physician profile
Mona Nataprawira
NPI 1528378965
$8,228.59
in general payments reported to CMS, 2019-2025
30 companies · $542 in 2025
The $542 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $483 · 2020: $78.77 · 2021: $148 · 2022: $532 · 2023: $551 · 2024: $5,894 · 2025: $542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,585 · Food and Beverage: $1,301 · Travel and Lodging: $1,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,585.00 |
| Food and Beverage | $1,301.32 |
| Travel and Lodging | $1,100.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,634.77 | 2024 | |
| Astellas Pharma US INC | $675.45 | 2019-2025 | Veozah |
| Abbvie INC. | $398.80 | 2019-2025 | |
| Amgen INC. | $154.47 | 2019-2025 | Prolia, Evenity |
| Hologic Sales and Service, LLC | $127.51 | 2019-2025 | Aptima |
| Organon LLC | $111.77 | 2021-2024 | |
| Sage Therapeutics, LLC | $111.28 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $109.49 | 2021-2024 | Slynd |
| Mayne Pharma Commercial LLC | $95.23 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.60 | 2019-2020 | |
| Pfizer INC. | $81.11 | 2022-2024 | |
| Pacira Pharmaceuticals Incorporated | $65.72 | 2024-2025 | Exparel, Zilretta, Iovera |
| Daiichi Sankyo INC. | $63.45 | 2019-2025 | Injectafer |
| Amag Pharmaceuticals, INC. | $63.42 | 2019-2020 | |
| Allergan, INC. | $61.70 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $61.33 | 2019-2022 | |
| Optumhealth Care Solutions, LLC | $55.67 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Exact Sciences Corporation | $50.72 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Organogenesis INC. | $40.63 | 2025 | Puraply Wound Matrix |
| Myovant Sciences INC. | $22.00 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $18.62 | 2025 | |
| Convatec INC. | $17.24 | 2022 | |
| Supernus Pharmaceuticals, INC. | $17.13 | 2025 | Qelbree |
| Currax Pharmaceuticals LLC | $16.75 | 2023 | Contrave |
| Agile Therapeutics, INC. | $16.15 | 2023 | Twirla |
| Sumitomo Pharma America, INC. | $15.95 | 2023 | Myfembree |
| Mylan Pharmaceuticals INC. | $15.94 | 2022 | |
| Minerva Surgical, INC | $15.52 | 2023 | |
| Duchesnay USA Incorporated | $15.10 | 2019 | |
| Boston Scientific Corporation | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Nataprawira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.